OPKO Health, Inc. Debt Instrument, Redemption Price, Percentage
OPKO Health, Inc. (OPK) reported Debt Instrument, Redemption Price, Percentage of 100.00% for the 6-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentRedemptionPricePercentage · last filed 2026-08-28
- OPKO Health, Inc. debt instrument, redemption price, percentage for the quarter ending 2026-03-31 was 100.00%.
- OPKO Health, Inc. debt instrument, redemption price, percentage for fiscal 2025 was 100.00%.
| Period end | Debt Instrument, Redemption Price, Percentage 3 month | Debt Instrument, Redemption Price, Percentage 6 month | Debt Instrument, Redemption Price, Percentage 9 month | Debt Instrument, Redemption Price, Percentage 12 month |
|---|---|---|---|---|
| 2026-06-30 | 100.00% 10-Q/A · filed 2026-08-28 | |||
| 2026-03-31 | 100.00% 10-Q/A · filed 2026-08-28 | |||
| 2025-12-31 | 100.00% 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 100.00% 10-Q · filed 2025-10-29 | |||
| 2025-06-30 | 100.00% 10-Q · filed 2025-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |